GlassScriptPhysician profile
Miles Alexander Soyer
NPI 1124861448
$1,343.54
in general payments reported to CMS, 2019-2025
10 companies · $896 in 2025
The $896 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $447 · 2025: $896.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,134 · Education: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,133.55 |
| Education | $209.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $340.88 | 2024-2025 | Dart-Fire, Variax |
| Medical Device Business Services, INC. | $209.99 | 2025 | Actis |
| Medtronic, INC. | $167.28 | 2025 | In.Pact Admiral |
| Smith+Nephew, INC. | $158.53 | 2024-2025 | Grafix Pl, Iodosorb Ointment 40g USA, Regranex |
| Mimedx Group, INC. | $133.85 | 2024-2025 | |
| Novastep INC. | $123.38 | 2024 | Nexis |
| Medline Industries LP | $112.17 | 2024 | |
| Bone Support INC. | $58.63 | 2025 | Cerament G, Ceramentbone Void Filler |
| Biocomposites INC | $31.56 | 2025 | Stimulan |
| Advanced Oxygen Therapy INC. | $7.27 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miles Soyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.